3256
A. G. M. Barrett, M. U. Frederiksen
PAPER
5614. (b) Masamune, S.; Kamata, S.; Schilling, W. J. Am.
Chem. Soc. 1975, 97, 3515. (c) Inanaga, J.; Hirata, K.;
Saeki, H.; Tatsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn.
1979, 52, 1989. (d) Boden, E. P.; Keck, G. E. J. Org. Chem.
1985, 50, 2394. (e) Steliou, K.; Szczygielska-Nowosielska,
A.; Favre, A.; Poupart, M. A.; Hanessian, S. J. Am. Chem.
Soc. 1980, 102, 7578. (f) Boeckman, R. K. Jr.; Pruitt, J. R. J.
Am. Chem. Soc. 1989, 111, 8286. (g) Trost, B. M.;
Chisholm, J. D. Org. Lett. 2002, 4, 3743.
O
7, basea
NH
TBSO
Br
OTBS
27
28
O
R1O
O
N
12
Esterifyb
R2
TBSO
(2) Mukaiyama, T.; Usui, M.; Saigo, K. Chem. Lett. 1976, 49.
(3) For an example of macrolactonisation using solid-supported
DCC, see: Keck, G. E.; Sanchez, C.; Wager, C. A.
Tetrahedron Lett. 2000, 41, 8673.
29 R1 = TES, R2 = Me
30 R1 = TBS, R2 = H
(4) (a) For the conversion of 6-(2,2¢-bipyridyl) esters into
amides with Zn(II), Co(II) or Ni(II) catalysis see: Propst, R.
M. III; Trzupek, L. S. J. Am. Chem. Soc. 1981, 103, 3233.
(b) For the transesterification of 6-(2,2¢-bipyridyl)esters and
alcohols catalysed by CsF, see: Mukaiyama, T.; Pai, F.-C.;
Onaka, M.; Narasaka, K. Chem. Lett. 1980, 563. For the
macrolactonization of hydroxyacids by reflux of their 6-
phenyl-2-pyridyl esters and 4-toluenesulfonic acid in
CH2Cl2 see: (c) Narasaka, K.; Yamaguchi, M.; Mukaiyama,
T. Chem. Lett. 1977, 959. (d) Mukaiyama, T.; Narasaka, K.;
Kikuchi, K. Chem. Lett. 1977, 441. (e) For the conversion
of 2-pyridyl thioesters into esters using silver(I) salts, see:
Gerlach, H.; Thalmann, A. Helv. Chim. Acta 1974, 57,
2661. (f) For the use of related thioesters with CuBr2
activation for the synthesis of cyclic oligo-(R)-3-
hydroxybutanoic esters, see: Lengweiler, U. D.; Fritz, M. G.;
Seebach, D. Helv. Chim. Acta 1996, 79, 670.
(5) (a) Mootoo, D. R.; Konradsson, P.; Udodong, U.;
FraserReid, B. J. Am. Chem. Soc. 1988, 110, 5583.
(b) Mootoo, D. R.; Date, V.; Fraser-Reid, B. J. Am. Chem.
Soc. 1988, 110, 2662. (c) Fraser-Reid, B.; Wu, Z.; Udodong,
U. E.; Ottosson, H. J. Org. Chem. 1990, 55, 6068.
(d) Fraser-Reid, B.; Udodong, U. E.; Wu, Z.; Ottosson, H.;
Merritt, J. R.; Rao, C. S.; Roberts, C.; Madsen, R. Synlett
1992, 927.
O
3HF⋅Et3Nc
HO
O
N
12
R2
HO
31 R2 = Me
32 R2 = H
O
O
Tf2Od
N
O
Me
11
34
33
Scheme 6 Reagents and conditions: (a) Pyridone 7, NaH (1 equiv);
n-BuLi (1 equiv), THF, 0–20 °C; 27, THF, –40 °C to 20 °C (61%); (b)
24 or 11, PyClU,12 Et3N, CH2Cl2, 0–20 °C [29 (79%); 30 (64%)]; (c)
3HF·Et3N, MeCN, 20 °C [31 (52%); 32 (71%)]; (d) R2 = Me, Tf2O,
Hünig’s base, CH2Cl2, –78 °C to 20 °C [33 (75%)] or –40 °C to 20 °C
[33 (82%)].
O
Acylatea
TBSO
O
N
H
O
N
14
(6) (a) For a review, see: van Maarseveen, J. H. Comb. Chem.
High Throughput Screening 1998, 1, 185. For additional
examples, see: (b) Nicolaou, K. C.; Roschangar, F.;
Vourloumis, D. Angew. Chem., Int. Ed. Engl. 1998, 37,
2014. (c) Nicolaou, K. C.; Winssinger, N.; Pastor, J.;
Murphy, F. Angew. Chem., Int. Ed. Engl. 1998, 37, 2534.
(d) Nicolaou, K. C.; Pastor, J.; Winssinger, N.; Murphy, F.
J. Am. Chem. Soc. 1998, 120, 5132.
35
36
O
3HF⋅Et3Nb
c
Cu(OTf)2
HO
14
O
N
14
37
Scheme 7 Reagents and conditions: (a) Acid 11, n-BuLi (1 equiv),
Et2O, 0 °C; (COCl)2, DMF (10 mol%); 35, Et3N, CH2Cl2, 0–20 °C
(38%); (b) 3HF·Et3N, MeCN, 20 °C (57%); (c) Cu(OTf)2 (1 equiv),
THF, 50 mM, 20 °C (83%).
(7) Rastetter, W. H.; Phillion, D. P. J. Org. Chem. 1981, 46,
3209.
(8) Sample identical (TLC, 1H and 13C NMR, GC–MS) with a
commercial sample.
(9) (a) For a related alkylation using a triflate, see: Bates, R. B.;
Taylor, S. R. J. Org. Chem. 1993, 58, 4469. (b) Prepared
from the addition of Tf2O to the corresponding alcohol and
anhyd PVP in CH2Cl2 at –78 °C (85%) and used directly
without purification: McDougal, P. G.; Rico, J. G.; Oh, Y. I.;
Condon, B. D. J. Org. Chem. 1986, 51, 3388.
(10) Graham, R. J.; Weiler, L. Tetrahedron Lett. 1991, 32, 1027.
(11) Cooper, M. S.; Heaney, H.; Newbold, A. J.; Sanderson, W.
R. Synlett 1990, 533.
Acknowledgment
We thank GlaxoSmithKline for the generous endowment (to
A.G.M.B.), the Royal Society and the Wolfson Foundation for a
Royal Society Wolfson Research Merit Award (to A.G.M.B.), the
Norwegian Research Council for pre-doctoral fellowship support
(to M.U.F), the Wolfson Foundation for establishing the Wolfson
Centre for Organic Chemistry in Medical Sciences at Imperial Col-
lege London, and the Engineering and Physical Sciences Research
Council for generous support of our studies.
(12) PyClU = N,N,N¢,N¢-bis(tetramethylene)chloroform-
amidinium hexafluorophosphate. See: Coste, J.; Frérot, E.;
Jouin, P. Tetrahedron Lett. 1991, 32, 1967.
(13) Kirkland, T. A.; Grubbs, R. H. J. Org. Chem. 1997, 62, 7310.
(14) Sample identical (TLC, 1H and 13C NMR, GCMS) with the
lactone intermediate in the synthesis of 24.
References
(1) (a) Corey, E. J.; Nicolaou, K. C. J. Am. Chem. Soc. 1974, 96,
Synthesis 2005, No. 19, 3253–3256 © Thieme Stuttgart · New York